Marshall Wace’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,366
Closed -$40K 3218
2025
Q4
$40K Buy
+15,366
New +$42K ﹤0.01% 2791
2025
Q3
Sell
-118,928
Closed -$478K 2919
2025
Q2
$478K Buy
118,928
+24,954
+27% +$92.1K ﹤0.01% 2166
2025
Q1
$313K Buy
93,974
+6,061
+7% +$28.9K ﹤0.01% 2253
2024
Q4
$543K Buy
+87,913
New +$511K ﹤0.01% 1999
2024
Q2
Sell
-10,900
Closed -$63.2K 2571
2024
Q1
$63.2K Buy
+10,900
New +$54.6K ﹤0.01% 2334
2022
Q2
Sell
-1,544,299
Closed -$15.3M 3444
2022
Q1
$15.3M Buy
1,544,299
+139
+0% +$1.37K 0.03% 609
2021
Q4
$15.2M Buy
1,544,160
+602,246
+64% +$5.88M 0.03% 609
2021
Q3
$9.17M Buy
941,914
+50,306
+6% +$487K 0.04% 609
2021
Q2
$8.66M Buy
+891,608
New +$8.75M 0.04% 551

Other funds holding BTMD

Marshall Wace's BTMD Position: Q1 2026 in Review

Marshall Wace sold out of Biote Corp (BTMD) in Q1 2026, closing a stake of 15,366 shares — an estimated $40K sold.

Marshall Wace first reported a position in BTMD in Q2 2021 and held it in 9 quarters. The position peaked at $15.3M in Q1 2022. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Marshall Wace reported no remaining Biote Corp position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 15,366 Biote Corp shares in Q1 2026, an estimated $40K.
  • Marshall Wace first reported a position in Biote Corp in Q2 2021 and held it in 9 quarters.
  • Marshall Wace's Biote Corp position peaked at $15.3M in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.